⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LEGN News
Legend Biotech Corporation American Depositary Shares
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
globenewswire.com
LEGN
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)
globenewswire.com
LEGN
Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026
globenewswire.com
LEGN
Legend Biotech Announces Presentations at ASCO 2026
globenewswire.com
LEGN
Pharmazz, Inc. Appoints Ajay Bansal as Chief Financial Officer
globenewswire.com
LEGN
NBIX
Legend Biotech Reports First Quarter 2026 Results and Recent Highlights
globenewswire.com
LEGN
Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth
globenewswire.com
LEGN
Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results
globenewswire.com
LEGN
Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights
globenewswire.com
LEGN
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results
globenewswire.com
LEGN